Novak P, Kovacech B, Katina S . ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease. Nat Aging. 1, 2021, pp521-34. Nat Aging.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Phase 2 Data of AADvac1 in Alzheimer’s Disease Published

Therapeutics

  1. AADvac1